Alzheimer’s experts greet China’s surprise approval of a drug for brain disease with hope and caution

A Chinese biotech startup has startled neuroscientists and drug developers with a new plant-based compound it claims improves cognitive function in Alzheimer’s patients by altering their gut microbiomes.

Source link

Related posts

The Robert Yates Charitable Fund donates $100K to the UF Trauma, Concussion & Sports Medicine Program


Judging Informed Consent


How marijuana affects the body


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy